Skip to Main content Skip to Navigation
Journal articles

CD146/sCD146 in the Pathogenesis and Monitoring of Angiogenic and Inflammatory Diseases

Abstract : CD146 is a cell adhesion molecule expressed on endothelial cells, as well as on other cells such as mesenchymal stem cells and Th17 lymphocytes. This protein also exists in a soluble form, whereby it can be detected in biological fluids, including the serum or the cerebrospinal fluid (CSF). Some studies have highlighted the significance of CD146 and its soluble form in angiogenesis and inflammation, having been shown to contribute to the pathogenesis of many inflammatory autoimmune diseases, such as systemic sclerosis, mellitus diabetes, rheumatoid arthritis, inflammatory bowel diseases, and multiple sclerosis. In this review, we will focus on how CD146 and sCD146 contribute to the pathogenesis of the aforementioned autoimmune diseases and discuss the relevance of considering it as a biomarker in these pathologies.
Document type :
Journal articles
Complete list of metadata

https://hal.inrae.fr/hal-03144556
Contributor : Nelly Lucas <>
Submitted on : Wednesday, February 17, 2021 - 4:54:39 PM
Last modification on : Monday, February 22, 2021 - 4:41:30 PM

Links full text

Identifiers

Collections

Citation

Xavier Heim, Ahmad Joshkon, Julien Bermudez, Richard Bachelier, Cléa Dubrou, et al.. CD146/sCD146 in the Pathogenesis and Monitoring of Angiogenic and Inflammatory Diseases. Biomedicines, MDPI, 2020, 8 (12), pp.592. ⟨10.3390/biomedicines8120592⟩. ⟨hal-03144556⟩

Share

Metrics

Record views

43